Week In Review: China's Innovent Raises $100 Million For Biologics Portfolio
ChinaBio Today - at Seeking Alpha - Sun Jan 25, 7:04AM CST
Deals and Financings Innovent Biologics of Suzhou announced a significant $100 million C round funding, which the company will use to advance its portfolio of eight biologic drug candidates. Founded in 2011, Innovent already has filed four IND...
CTLT: 27.52 (-1.06), PKI: 46.30 (-0.10)